Not a good buy right now for an impatient investor: the setup lacks a clear technical buy trigger, and Wall Street’s latest notable view is bearish with a price target below the current price.
Current price ($57.38) is well above the provided resistance band (R2 ~$54.79), which makes risk/reward unfavorable for a fresh entry unless you’re specifically chasing a breakout.
No Intellectia proprietary buy signals (AI Stock Picker / SwingMax) to override other mixed-to-negative signals.
Near-term catalysts (earnings + dividend) exist, but fundamentals show margin and earnings pressure despite revenue growth.
Technical Analysis
Trend/price location: price ($57.38) is above the listed pivot/resistance levels (Pivot ~$53.41; R2 ~$54.79), implying the stock is extended versus those reference levels rather than sitting at a clean support-based entry.
Momentum: MACD histogram is slightly negative (-0.00389) and negatively expanding, suggesting weakening momentum.
RSI(6): 30.82 (low/near-oversold zone), which can precede a bounce, but it’s not confirmed given the negative MACD momentum.
Moving averages: converging MAs typically indicate consolidation/indecision rather than a strong trend.
Sentiment split: open interest put/call ratio at 0.68 leans bullish positioning (more calls outstanding), but the option volume put/call ratio at 2.6 is bearish for the day (puts traded outweigh calls).
Activity: today’s option volume is low in absolute terms (18 contracts) but flagged as elevated versus its 30-day average (today vs avg_30_day = 41.86), suggesting a relative spike off a small base.
Volatility: 30D IV ~29.74 vs historical vol ~27.93 (slightly higher IV), with IV percentile ~55.6 (mid-range), not signaling extreme fear/greed.
Net read: options are not giving a clean bullish confirmation for an immediate buy; flow looks more protective/defensive today.
Technical Summary
Sell
5
Buy
7
Positive Catalysts
on/around Feb 19, 2026 pre-market (calendar provided) with another results release noted for Feb 26, 2026 (headline), which can re-rate the stock if results/forward commentary surprise positively.
Neutral/Negative Catalysts
Analyst pressure: BofA kept an Underperform rating and cut price target to $51 (below current $57.38), a notable headwind for near-term upside.
Technical momentum not supportive: MACD histogram negative and worsening, with no proprietary buy signals.
Event risk: earnings upcoming—any miss or cautious guidance can hit the units quickly, especially if the price is already extended versus prior resistance.
No notable supportive positioning signal: hedge funds and insiders reported as neutral; no “smart money” tailwind indicated in the provided trends.
Politicians/influencers: no recent congress trading data available in the last 90 days (no visible policy-trading tailwind).
Financial Performance
Latest quarter provided: 2025/Q3.
Growth: revenue rose to $2.404B (+16.98% YoY), showing strong top-line growth.
Profitability deterioration: net income fell to $388M (-25.95% YoY) and EPS fell to $0.80 (-25.93% YoY).
Margin compression: gross margin dropped to 30.03 (-27.83% YoY), indicating costs/pricing dynamics pressured profitability even as revenue grew.
Overall read: improving sales but worsening earnings power—this mix typically limits near-term multiple expansion unless margins stabilize.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend (from the data provided): BofA (Dec 11, 2025) reiterated Underperform and reduced the price target from $53 to $51.
Wall Street pros view (pros): revenue growth remains solid; income/distribution profile can be attractive; LNG-related business often benefits from structural demand.
Wall Street cons view (cons): margin/EPS decline raises quality-of-earnings concerns; the highlighted target is meaningfully below the current price, implying limited upside and potential downside if fundamentals don’t re-accelerate.
Net analyst takeaway from the provided note: bearish/underperform stance dominates the latest cited coverage.
Wall Street analysts forecast CQP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CQP is 58.2 USD with a low forecast of 51 USD and a high forecast of 71 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast CQP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CQP is 58.2 USD with a low forecast of 51 USD and a high forecast of 71 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
3 Sell
Moderate Sell
Current: 57.660
Low
51
Averages
58.2
High
71
Current: 57.660
Low
51
Averages
58.2
High
71
BofA
Jean Ann Salisbury
Underperform
downgrade
$53 -> $51
AI Analysis
2025-12-11
Reason
BofA
Jean Ann Salisbury
Price Target
$53 -> $51
AI Analysis
2025-12-11
downgrade
Underperform
Reason
BofA analyst Jean Ann Salisbury lowered the firm's price target on Cheniere Energy Partners to $51 from $53 and keeps an Underperform rating on the shares.
Barclays
Underweight
downgrade
$56 -> $55
2025-08-14
Reason
Barclays
Price Target
$56 -> $55
2025-08-14
downgrade
Underweight
Reason
Barclays lowered the firm's price target on Cheniere Energy Partners to $55 from $56 and keeps an Underweight rating on the shares. The firm updated models in the midstream and refining group post the Q2 reports.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CQP